BR9609053A - Métodos de induzir fator de transcrição de bef-1 - Google Patents

Métodos de induzir fator de transcrição de bef-1

Info

Publication number
BR9609053A
BR9609053A BR9609053A BR9609053A BR9609053A BR 9609053 A BR9609053 A BR 9609053A BR 9609053 A BR9609053 A BR 9609053A BR 9609053 A BR9609053 A BR 9609053A BR 9609053 A BR9609053 A BR 9609053A
Authority
BR
Brazil
Prior art keywords
bef
inducing
methods
transcription factor
transcription
Prior art date
Application number
BR9609053A
Other languages
English (en)
Inventor
David Scott Calnek
David Thompson Berg
Brian William Grinnell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9609053A publication Critical patent/BR9609053A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BR9609053A 1995-06-07 1996-06-05 Métodos de induzir fator de transcrição de bef-1 BR9609053A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47949895A 1995-06-07 1995-06-07
PCT/US1996/008752 WO1996040130A1 (en) 1995-06-07 1996-06-05 Methods of inducing bef-1 transcription factor

Publications (1)

Publication Number Publication Date
BR9609053A true BR9609053A (pt) 1999-01-26

Family

ID=23904277

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609053A BR9609053A (pt) 1995-06-07 1996-06-05 Métodos de induzir fator de transcrição de bef-1

Country Status (8)

Country Link
EP (1) EP0747051B1 (pt)
JP (1) JPH11506771A (pt)
AU (1) AU6040296A (pt)
BR (1) BR9609053A (pt)
CA (1) CA2223175A1 (pt)
DE (1) DE69622472T2 (pt)
ES (1) ES2180702T3 (pt)
WO (1) WO1996040130A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990129A (en) * 1997-09-23 1999-11-23 Eli Lilly And Company Methods for regulating trkA expression
CA2584507C (en) 2004-10-20 2016-04-26 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
US8410109B2 (en) 2005-07-29 2013-04-02 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
NZ579355A (en) 2007-02-01 2012-03-30 Resverlogix Corp 2-(Aryl)-4-oxo-quinazoline derivatives
ES2532402T3 (es) 2008-06-26 2015-03-26 Resverlogix Corporation Métodos de preparación de derivados de quinazolinona
ES2463097T3 (es) 2009-01-08 2014-05-27 Resverlogix Corp. Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
CA2992231C (en) 2009-03-18 2022-03-29 Resverlogix Corp. Phenyl-quinazolin-4(3h)-one and phenyl-pyrido[2,3-d]pyrimidin-4(3h)-one derivatives and compositions thereof useful as anti-inflammatory agents
PL2421533T3 (pl) 2009-04-22 2019-05-31 Resverlogix Corp Nowe środki przeciwzapalne
KR102011641B1 (ko) 2011-11-01 2019-08-19 리스버로직스 코퍼레이션 치환된 퀴나졸리논을 위한 경구 즉시 방출 제형
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
EP2935253B1 (en) 2012-12-21 2018-08-01 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
JP6903585B2 (ja) 2015-03-13 2021-07-14 レスバーロジックス コーポレイション 補体関連疾患の治療のための組成物および治療方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
US5492927A (en) * 1993-12-21 1996-02-20 Eli Lilly And Company Non-peptide tachykinin receptor antagonists to treat allergy
US5476862A (en) * 1993-12-21 1995-12-19 Eli Lilly And Company Methods of increasing thrombomodulin expression
TW427902B (en) * 1993-12-21 2001-04-01 Lilly Co Eli Pharmaceutical composition for inhibiting low-density lipoprotein (LDL) oxidation and atherosclerosis
US5545641A (en) * 1994-10-20 1996-08-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of bradykinin

Also Published As

Publication number Publication date
AU6040296A (en) 1996-12-30
EP0747051B1 (en) 2002-07-24
EP0747051A2 (en) 1996-12-11
WO1996040130A1 (en) 1996-12-19
DE69622472T2 (de) 2003-02-06
JPH11506771A (ja) 1999-06-15
ES2180702T3 (es) 2003-02-16
CA2223175A1 (en) 1996-12-19
DE69622472D1 (de) 2002-08-29
EP0747051A3 (en) 1997-02-26

Similar Documents

Publication Publication Date Title
FI19992060A (fi) Prosessikojeen alusta
BR9609772A (pt) Redução de bioincrustações
DE69608101D1 (de) Endodonotischer instrumentensatz
LV11983A (lv) Iekskigi lietojams 2-metil-tieno-benzodiazepina zalu preparats
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
NO991382D0 (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
BR9609053A (pt) Métodos de induzir fator de transcrição de bef-1
DE69625049D1 (de) Fluginstrumentenanzeigen
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
EE9900420A (et) Kõnesünteesi juurde kuuluv meetod
ITMI951715A0 (it) Metodo per la preparazione della 1-b-d-arabinofuranosilcitosina
NO980862D0 (no) Zwitterinoformer av trovafloxacin
IT1290151B1 (it) Procedimento migliorato per la produzione di 5-idrossimetiltiazolo
FI953319A0 (fi) Dimetyylinaftaleenin valmistus
FI960790A0 (fi) Menetelmä fluoreenibisfenolin valmistamiseksi
UA25110A (uk) Спосіб біліосорбції
UA24720A (uk) Спосіб алотраhсплаhтації hирки
UA25946C2 (uk) Спосіб одержаhhя гліцираму
DK0747365T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af
UA25109A (uk) Спосіб створюваhhя холедоходуодеhоаhастомозу
KR970011853U (ko) 새로운 형태의 메리야스
KR970041939U (ko) 부품의 방진체결구조
UA1112S (uk) Мікро-еом широкого призначення
FI953715A0 (fi) Faergavstoetande braennmaolningshaengare
KR970026379U (ko) 스피커의 방향 조정 장치

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal